1.
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls
by Ye, Zheng
The Lancet (British edition), 2006, Vol.367 (9511), p.651-658
2.
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease
by Wiseman, Stewart J
Cerebrovascular diseases (Basel, Switzerland), 2015-09, Vol.40 (3-4), p.157-164
3.
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
by Welsh, Paul
Cerebrovascular diseases (Basel, Switzerland), 2009-03, Vol.27 (3), p.247-253
4.
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
by Timpson, Nicholas J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1954-1959
5.
Genetic Associations for Activated Partial Thromboplastin Time and Prothrombin Time, their Gene Expression Profiles, and Risk of Coronary Artery Disease
by Tang, Weihong
American journal of human genetics, 2012-07-13, Vol.91 (1), p.152-162
6.
Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study
by GIMENO, David
European journal of epidemiology, 2007-10-01, Vol.22 (10), p.675-683
7.
An Analysis of Prospective Risk Factors for Aortic Stiffness in Men: 20-Year Follow-Up From the Caerphilly Prospective Study
by McEniery, Carmel M
Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.36-43
8.
Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time
by Houlihan, Lorna M
American journal of human genetics, 2010, Vol.86 (4), p.626-631
9.
Thromboprophylaxis for patients at high risk of VTE
by Lowe, Gordon
The Lancet (British edition), 2008, Vol.372 (9643), p.1037-1038
10.
Associations of Circulating C-Reactive Protein and Interleukin-6 with Cancer Risk: Findings from Two Prospective Cohorts and a Meta-Analysis
by Heikkilä, Katriina
Cancer causes & control, 2009-02-01, Vol.20 (1), p.15-26
11.
Is venous thrombosis a risk factor for arterial thrombosis?
by Lowe, Gordon DO
The Lancet (British edition), 2007, Vol.370 (9601), p.1742-1744
12.
Blood Biomarkers for the Diagnosis of Acute Cerebrovascular Diseases: A Prospective Cohort Study
by Whiteley, William
Cerebrovascular diseases (Basel, Switzerland), 2011-08, Vol.32 (2), p.141-147
13.
Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study
by Marioni, Riccardo E
Age and ageing, 2010-05, Vol.39 (3), p.354-359
14.
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
by Lowe, Gordon DO
The Lancet (British edition), 2003, Vol.362 (9383), p.504-505
15.
Total tooth loss and prevalent cardiovascular disease in men and women: Possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombotic variables
by Lowe, Gordon
Journal of clinical epidemiology, 2003, Vol.56 (7), p.694-700
16.
Inflammation, coagulation and risk of locomotor disability in elderly women: findings from the British Women's Heart and Health Study
by NÜESCH, Eveline
European journal of epidemiology, 2012-01-01, Vol.27 (8), p.633-645
17.
Statin therapy and the acute inflammatory response after coronary artery bypass grafting
by Brull, David J
The American journal of cardiology, 2001-08-15, Vol.88 (4), p.431-433
18.
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment
by Lip, G. Y
British Heart Journal, 1995-06, Vol.73 (6), p.527-533
19.
A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome
by KELLY, Christopher J. G
The journal of clinical endocrinology and metabolism, 2002, Vol.87 (7), p.3287-3290
20.
Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction
by Weir, Robin A. P
Journal of thrombosis and thrombolysis, 2009-08-07, Vol.29 (4), p.421-428
